CurrentCardio
Get Weekly

Topic · page 4 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 121–160 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Eur J Heart Fail

    Diurnal variation in left atrial pressure in ambulatory patients with chronic heart failure

    Cohort study

  2. Lancet

    Targeted left ventricular lead placement in biventricular pacing for heart failure: a national, multicentre, double-blind, randomised controlled trial in Denmark

    Randomised controlled trial

  3. Eur Heart J

    Auto-regulated bioprosthetic total artificial heart as bridge to transplantation: the EFICAS study

    Cohort study

  4. Eur Heart J Qual Care Clin Outcomes

    Economic evaluations of invasive devices for remote cardiac monitoring in chronic heart failure: a scoping review

    Research article

  5. Eur Heart J Acute Cardiovasc Care

    Prognostic impact of pericardial effusion in patients with acute myocarditis

    Cohort study

  6. Lancet

    Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study

    Cohort study

  7. JACC Heart Fail

    Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure: An Analysis of the DAPA ACT HF-TIMI 68 Trial

    Secondary analysis

  8. JAMA

    Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials

    Meta-analysis

  9. JAMA

    124 I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial

    Diagnostic or prognostic study

  10. J Am Coll Cardiol

    Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis

    Secondary analysis

  11. J Am Coll Cardiol

    Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B

    Secondary analysis

  12. Nat Med

    Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial

    Secondary analysis

  13. JACC Cardiovasc Imaging

    124Iodine Evuzamitide Positron Emission Tomography in Patients With Established or Suspected Cardiac Amyloidosis

    Diagnostic or prognostic study

  14. Circulation

    Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India

    Randomised controlled trial

  15. N Engl J Med

    Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension

    Randomised controlled trial

  16. Circulation

    Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial

    Randomised controlled trial

  17. Eur Heart J Cardiovasc Imaging

    Non-invasive estimation of right atrial pressure using magnetic resonance imaging: a development and validation study

    Diagnostic or prognostic study

  18. Eur J Prev Cardiol

    Sport Type Alone Does Not Reliably Predict Distinct Cardiac Phenotypes in Athletes

    Cross-sectional study

  19. Eur J Heart Fail

    Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials

    Meta-analysis

  20. JACC Heart Fail

    Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM

    Secondary analysis

  21. Circulation

    Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

    Secondary analysis

  22. Eur J Heart Fail

    Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States

    Research article

  23. J Am Coll Cardiol

    Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure

    Meta-analysis

  24. JACC Adv

    Diffuse Fibrosis in Hypertrophic Cardiomyopathy: Incremental Prognostic Value of Extracellular Volume

    Cohort study

  25. JACC Heart Fail

    Myocardial Histopathology-Based Heart Failure Phenotyping

    Cohort study

  26. JACC Heart Fail

    Cardiac Function and the Effect of Heart Failure Treatment in Patients With Genotype-Positive Dilated Cardiomyopathy

    Cohort study

  27. Europace

    Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

    Guideline or statement

  28. JAMA

    Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy

    Diagnostic or prognostic study

  29. JAMA Cardiol

    Machine Learning–Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy

    Cohort study

  30. Circulation

    Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM

    Secondary analysis

  31. N Engl J Med

    Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

    Randomised controlled trial

  32. N Engl J Med

    Eplontersen for Transthyretin Amyloid Cardiomyopathy

    Randomised controlled trial

  33. Eur Heart J

    Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study

    Cohort study

  34. Eur Heart J

    Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study

    Diagnostic or prognostic study

  35. JACC Heart Fail

    HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial

    Secondary analysis

  36. Circ Heart Fail

    Sex Differences in Skeletal Muscle Inflammation and Dysfunction in Patients With Heart Failure and Reduced Ejection Fraction

    Research article

  37. J Am Coll Cardiol

    Physiological Left Atrial Staging and the Risk of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy

    Cohort study

  38. JACC Adv

    Prevalence of Pathogenic Genetic Variants Across Heart Failure Etiologies in an Admixed Population

    Cohort study

  39. JAMA Cardiol

    Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial

    Secondary analysis

  40. JACC Clin Electrophysiol

    Clinical Impact of Arrhythmias Detected by an Implantable Cardiac Monitoring Device With Real-Time Transmission Among Patients With Early Reduced Left Ventricular Ejection Fraction After ST-Segment Elevation Acute Myocardial Infarction: The TeVeO Study

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 121–160 of 1,928, newest first